Celon Pharma S.A. conducts research into innovative drugs in four therapeutic area – diabetes, oncology, neurodegenerative diseases and inflammatory diseases. We have a team of extremely well educated, experienced and involved scientists who began their careers in Celon Pharma S.A. out of passion for science. Through the use of modern tools for modelling of low molecular weight compounds in silico, we can easily design our own libraries of potential candidates for new drugs. The use of algorithms for multi-parameter optimisation of physico-chemical compounds allows for efficient selection of the most attractive compounds for synthesis and subsequent structural optimisation. The combination of knowledge accumulated from calculations, retrosynthetic knowledge and a broad analysis of publications and patents, with close cooperation with the Department of Preclinical Trials and the Department of Medicinal Product Development, allows us to carry out projects efficiently and quickly develop a potential drug, starting from the idea, through in silico modelling, analysis of physico-chemical parameters and chemical synthesis, up to proof-of-concept studies.
We believe that the key to success is team work, openness of mind and passion.